Tag: Exeliom Biosciences

Browse exclusive Tags!

Paris-based Exeliom Biosciences secures €24 million in Series A funding for advancement of microbiome-based immunotherapy

Exeliom Biosciences secures €24 million funding for microbiome-based immunotherapy development.

Popular

Subscribe

spot_imgspot_img